Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Kobayashi Pharmaceutical President Norikazu Toyoda in Osaka on May 30
BUSINESS / Companies
Jun 4, 2025
Kobayashi Pharmaceutical vows never to repeat health crisis
In March 2024, the drugmaker, based in Osaka, announced that it had received a series of reports about such symptoms as kidney disease from users of its supplements.
Tsuruha shareholders approved a merger plan with Welcia, which will result in an effective acquisition by supermarket chain Aeon.
BUSINESS
May 26, 2025
Tsuruha shareholders approve future merger with rival drugstore Welcia
Tsuruha, based in Sapporo, has announced it will integrate its operations with Welcia, the biggest force within the Japanese pharmacy industry, in December.
The lack of quick and easy tests has until now slowed the rollout of new Alzheimer’s drugs.
WORLD / Science & Health
May 20, 2025
First blood test for Alzheimer’s to be available in U.S. in June
The test will initially be available at about 50 American research institutes and hospitals that specialize in Alzheimer’s disease.
People shop inside a tax-free drug store at the Ameyoko shopping district in Tokyo on Thursday.
JAPAN / Science & Health
May 16, 2025
Emergency contraceptive pill may be approved for over-the-counter sales
In most cases, women in Japan must undergo a medical examination and obtain a prescription to access such pills.
From around spring 2027, people will be able to pick up over-the-counter drugs from convenience stores without pharmacists in Japan.
JAPAN
May 15, 2025
Over-the-counter drugs to be made available at convenience stores
The move will require consumers to listen to explanations from pharmacists online before purchases.
Capsules of Takeda Pharmaceutical's Prevacid heartburn drug. The company's share price dropped by over 5% on Monday after U.S. President Donald Trump announced a plan to order a cut in U.S. prescription drug costs.
BUSINESS / Markets
May 12, 2025
Asian pharma stocks tumble on Trump signal to cut U.S. drug prices
The U.S. president's social media post put pressure on drug-related stocks on worries their profits will take a hit if they have to reduce prices in the U.S.
Shares of Eli Lilly & Co. surged on the New York Stock Exchange on Thursday after early reports of its experimental weight-loss drug put in a par with market leader Ozempic. The stocks of the drug’s originator, Chugai Pharmaceutical Co., also saw an uptick.
BUSINESS / Companies
Apr 18, 2025
Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai
Eli Lilly’s orforglipron pill, licensed from Chugai Pharmaceutical, could reshape the booming weight-loss drug market, early data shows.
The U.S. Commerce Department has begun investigating how semiconductors and pharmaceuticals impact national security.
BUSINESS / Economy
Apr 15, 2025
Trump initiates chips and drug probes, ahead of more tariffs
The moves, announced Monday in the Federal Register, are a precursor to imposing tariffs and threaten to broaden the president’s sweeping U.S. trade war.
Obstetrician and gynecologist Song Mihyon
JAPAN / Science & Health
Mar 7, 2025
Doctor urges awareness of a birth control pill covered by health insurance
“I think doctors need to tell their patients that a birth control pill covered by health insurance exists,” Song Mihyon said.
Foster City, California’s Gilead is laser-focused on HIV and is seeking an actual cure.
BUSINESS / Companies
Mar 6, 2025
Gilead's Japan head says nation can be among first to end HIV epidemic
The pharmaceutical powerhouse has drugs that disrupt the transmission of the virus, one of which has been approved for prevention in Japan.
Kesa Hatamoto, a 102-year-old Japanese woman who is recognized by Guinness World Records as the world's oldest pharmacist, speaks during an interview on Jan. 28 in Tokyo's Meguro Ward.
JAPAN
Mar 6, 2025
At 102, world's oldest pharmacist celebrates her calling
"There's nothing happier than having a job for a lifetime. I want to continue my career forever," says Kesa Hatamoto.
Blackstone said it agreed to purchase 60% of Tokyo-based CMIC, a contract research organization, in a deal that values the company in the hundreds of millions of dollars.
BUSINESS / Companies
Mar 3, 2025
Blackstone buys Japan drug trial firm, adding to private equity health deals
Blackstone has been increasingly active in Japan’s life science sector amid a wider buyout boom in the country.
Newly manufactured cars ready for shipping. U.S. President Donald Trump said he is likely to impose new 25% tariffs on imported cars, semiconductors and pharmaceuticals in the coming months.
BUSINESS / Markets
Feb 19, 2025
Trump floats 25% tariffs on U.S. auto, drug and chip imports
The U.S. president has also threatened other streams of tariffs, all part of an effort to reconfigure the country's trading relationships across the globe.
Too many people die from treatable diseases in places with little access to health care. To prevent this from happening, affordability, availability and acceptability considerations must be at the core of medical products' lifecycles, starting with R & D.
COMMENTARY / World
Feb 13, 2025
To stop preventable deaths, start with the fundamentals
Treatable diseases like malaria are still causing too many deaths in places with poor health care. To prevent these, accessibility must be baked into medical development.
Kobayashi Pharmaceutical President and CEO Satoshi Yamane apologizes for the company's health hazard scandal involving its supplement products during a news conference in Osaka on Monday.
BUSINESS / Companies
Feb 11, 2025
Kobayashi Pharma logs first net profit drop since 1999 listing
The company's net profit plunged 50.5% in the aftermath of a health scandal involving its supplements, which emerged last year.
Mitsubishi Tanabe Pharma will be acquired by U.S. private equity firm Bain Capital for ¥510 billion.
BUSINESS / Companies
Feb 9, 2025
Bain to acquire Mitsubishi Tanabe Pharma in $3.3 billion deal
Tanabe Pharma focuses on therapeutic areas such as immunology and inflammation, vaccines, diabetes, and central nervous system and metabolic disease.
Fentanyl precursors on display in Mexico City on Oct. 4, 2023. Chemical components are said to be shipped from China to Mexico, where they are then made into fentanyl and smuggled across the border.
ASIA PACIFIC / Crime & Legal
Feb 4, 2025
How China allegedly contributes to the deadly fentanyl crisis
Chemical components are said to be shipped from China to Mexico, where they are then made into fentanyl and smuggled across the border.
AstraZeneca and Daiichi Sankyo’s Datroway breast cancer treatment, which the companies expect will eventually become a blockbuster, was recommended for approval in the European Union.
BUSINESS
Jan 31, 2025
AstraZeneca and Daiichi’s breast cancer drug gets EU backing
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in the U.S. and Japan.
Takeda Pharmaceutical's headquarters in Tokyo
BUSINESS / Companies
Jan 30, 2025
Takeda picks first female CEO of centuries-old drugmaker
Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, subject to shareholder approval, the company said.
Kobayashi Pharmaceutical executives bow their heads at a news conference in Osaka in March following a health hazard scandal involving the firm's supplements containing red fermented rice.
JAPAN / Crime & Legal
Jan 29, 2025
Hong Kong fund to sue former Kobayashi Pharma execs
The fund will seek a total of roughly ¥11 billion in damages from former Chairman Kazumasa Kobayashi and six then-board directors.

Longform

Sumadori Bar on Shibuya Ward's main Center Gai street targets young customers who prefer low-alcohol drinks or abstain altogether.
Rethinking that second drink: Japan’s Gen Z gets ‘sober curious’